Encouraging Improvement in Cytopenias of Patients With Myelodysplastic Syndromes With Thalidomide
November 1st 2000Myelodysplastic syndrome patients present with variable cytopenias even though their bone marrows are generally hypercellular. Excessive cytokine-induced apoptosis of hematopoietic cells in the marrows has been proposed as a possible